Related Experiment Video

Updated: Jul 12, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.0K

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer

Xiaoxin Xu1, Jiayao Zhao1, Mingyue Yang2

  • 1Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, People's Republic of China.

European Journal of Medical Research
|November 2, 2023
PubMed

Insights

N6-methyladenosine (m6A) RNA modification impacts thyroid cancer (TC) progression and drug resistance. Aberrant m6A regulators offer potential as prognostic markers and therapeutic targets for this endocrine malignancy.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyroid cancer (TC) is a prevalent endocrine malignancy with increasing incidence.
  • The molecular mechanisms driving TC pathogenesis are not fully understood.
  • N6-methyladenosine (m6A) RNA modification influences RNA metabolism and gene regulation.

Purpose of the Study:

  • To review the role of m6A methylation in thyroid cancer progression.
  • To analyze the clinical potential of m6A regulators in TC.
  • To identify m6A regulators as prognostic markers and therapeutic targets.

Main Methods:

  • Comprehensive literature review of m6A methylation in thyroid cancer.
  • Analysis of m6A regulators' expression and function in TC.
  • Evaluation of m6A regulators' association with TC prognosis and drug resistance.

Main Results:

  • Aberrant expression of m6A regulators is linked to TC occurrence and development.
  • m6A modification plays a significant role in TC progression.
  • m6A regulators are implicated in TC drug resistance.

Conclusions:

  • m6A methylation is a critical factor in thyroid cancer pathogenesis.
  • m6A regulators hold promise as prognostic biomarkers for TC.
  • Targeting m6A regulators may represent a novel therapeutic strategy for thyroid cancer.
Keywords:
N6-MethyladenosinePrognosisProgressionThyroid cancerTreatment

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.4K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.3K

Related Concept Videos

RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.6K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
12.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.0K